The longitudinal imaging tracker (Brics-lit): A cloud platform for monitoring treatment response in glioblastoma patients

Karthik Ramesh, Saumya S. Gurbani, Eric A. Mellon, Vicki Huang, Mohammed Goryawala, Peter B. Barker, Lawrence Kleinberg, Hui Kuo G. Shu, Hyunsuk Shim, Brent D. Weinberg

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Glioblastoma is a common and aggressive form of brain cancer affecting up to 20,000 new patients in the US annually. Despite rigorous therapies, current median survival is only 15–20 months. Patients who complete initial treatment undergo follow-up imaging at routine intervals to assess for tumor recurrence. Imaging is a central part of brain tumor management, but MRI findings in patients with brain tumor can be challenging to interpret and are further confounded by interpretation variability. Disease-specific structured reporting attempts to reduce variability in imaging results by implementing well-defined imaging criteria and standardized language. The Brain Tumor Reporting and Data System (BT-RADS) is one such framework streamlined for clinical workflows and includes quantitative criteria for more objective evaluation of follow-up imaging. To facilitate accurate and objective monitoring of patients during the follow-up period, we developed a cloud platform, the Brain Imaging Collaborative Suite’s Longitudinal Imaging Tracker (BrICS-LIT). BrICS-LIT uses semiautomated tumor segmentation algorithms of both T2-weighted FLAIR and contrast-enhanced T1-weighted MRI to assist clinicians in quantitative assessment of brain tumors. The LIT platform can ultimately guide clinical de-cision-making for patients with glioblastoma by providing quantitative metrics for BT-RADS scoring. Further, this platform has the potential to increase objectivity when measuring efficacy of novel therapies for patients with brain tumor during their follow-up. Therefore, LIT will be used to track patients in a dose-escalated clinical trial, where spectroscopic MRI has been used to guide radiation therapy ( NCT03137888), and compare patients to a control group that received standard of care.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
Issue number2
StatePublished - Jun 2020


  • Glioblastoma
  • Longitudinal tracking
  • Segmentation
  • Structured reporting

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'The longitudinal imaging tracker (Brics-lit): A cloud platform for monitoring treatment response in glioblastoma patients'. Together they form a unique fingerprint.

Cite this